Literature DB >> 1825076

Steroid hormone abnormalities in women with severe idiopathic constipation.

M A Kamm1, M J Farthing, J E Lennard-Jones, L A Perry, T Chard.   

Abstract

Patients with severe idiopathic constipation are almost exclusively women of reproductive age. To investigate the possibility of a sex hormone abnormality in this condition, we have compared a range of sex hormones during the follicular and luteal phases of the menstrual cycle in 23 healthy women (mean age 33 years) with those in 26 patients with severe idiopathic constipation (mean age 32 years, spontaneous bowel frequency less than one per week). In the patients there was a reduction in the follicular phase of progesterone (4.5 v 4 nmol/l, p = 0.006, median value, controls v patients), 17 hydroxyprogesterone (9.7 v 5.8 nmol/l, p = 0.01), cortisol (387 v 245 nmol/l, p = 0.008), testosterone (2.3 v 1.8 nmol/l, p less than 0.001), androstenedione (10.3 v 8.4 nmol/l, p = 0.02), and dehydroepiandrosterone sulphate (5.1 v 3.0 mumol/l, p = 0.03). In the luteal phase there was a reduction of oestradiol (483 v 350 pmol/l, p = 0.015), cortisol (322 v 242 nmol/l, p = 0.047), and testosterone (2.4 v 1.7 nmol/l, p = 0.003). The concentrations of sex hormone binding globulin, prolactin, luteinising hormone, and follicle stimulating hormone were not significantly different in either phase of the cycle. Women with severe idiopathic constipation have a consistent reduction in steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825076      PMCID: PMC1379219          DOI: 10.1136/gut.32.1.80

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

Review 1.  Anatomical and pathoanatomical studies on the spinal efferent systems innervating pelvic structures. 1. Organization of spinal nuclei in animals. 2. The nucleus X-pelvic motor system in man.

Authors:  H D Schrøder
Journal:  J Auton Nerv Syst       Date:  1985-09

2.  Bowel function and transit rate during the menstrual cycle.

Authors:  M A Kamm; M J Farthing; J E Lennard-Jones
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

3.  A ne method for studying gut transit times using radioopaque markers.

Authors:  J M Hinton; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

4.  Gastric emptying time in late pregnancy and labour.

Authors:  J S Davison; M C Davison; D M Hay
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-01

5.  Measurement of circulating corticotrophin-releasing factor in man.

Authors:  D Cunnah; D S Jessop; G M Besser; L H Rees
Journal:  J Endocrinol       Date:  1987-04       Impact factor: 4.286

6.  Physiological studies in young women with chronic constipation.

Authors:  J J Bannister; J M Timms; L J Barfield; T C Donnelly; N W Read
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

7.  Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women.

Authors:  G K Turnbull; D G Thompson; S Day; J Martin; E Walker; J E Lennard-Jones
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

8.  Ultrasonography shows no abnormality of pelvic structures in women with severe idiopathic constipation.

Authors:  M A Kamm; A McLean; M J Farthing; J E Lennard-Jones
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

9.  Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development?

Authors:  J M Holly; C P Smith; D B Dunger; R J Howell; T Chard; L A Perry; M O Savage; S Cianfarani; L H Rees; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1989-09       Impact factor: 3.478

10.  A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females.

Authors:  N C Wathen; L A Perry; E Rubenstein; T Chard
Journal:  Gynecol Endocrinol       Date:  1987-03       Impact factor: 2.260

View more
  8 in total

1.  Is the DHEAS/cortisol ratio a potential filter for non-operable constipated cases?

Authors:  A M El-Tawil
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

2.  Effects of female steroid hormones on A-type K+ currents in murine colon.

Authors:  Elizabeth A H Beckett; Conor McCloskey; Neil O'Kane; Kenton M Sanders; Sang Don Koh
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

Review 3.  Constipation. Pathogenesis and management.

Authors:  A Shafik
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

4.  Constipation and diarrhea during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nini G L Callan; Ellen S Mitchell; Margaret M Heitkemper; Nancy F Woods
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

5.  Overexpression of progesterone receptor B increases sensitivity of human colon muscle cells to progesterone.

Authors:  Ling Cheng; Victor Pricolo; Piero Biancani; Jose Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09       Impact factor: 4.052

Review 6.  Diagnosis and treatment of chronic constipation--a European perspective.

Authors:  J Tack; S Müller-Lissner; V Stanghellini; G Boeckxstaens; M A Kamm; M Simren; J-P Galmiche; M Fried
Journal:  Neurogastroenterol Motil       Date:  2011-05-24       Impact factor: 3.598

7.  Sex ratio of infants born to women with severe chronic constipation.

Authors:  Wh James
Journal:  Clin Epidemiol       Date:  2011-03-02       Impact factor: 4.790

8.  Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice.

Authors:  Daniella Rastelli; Ariel Robinson; Valentina N Lagomarsino; Lynley T Matthews; Rafla Hassan; Kristina Perez; William Dan; Peter D Yim; Madison Mixer; Aleksandra Prochera; Amy Shepherd; Liang Sun; Kathryn Hall; Sarah Ballou; Anthony Lembo; Judy Nee; Meenakshi Rao
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.